UN General Assembly's Resolution 74/306
Strategy document
United Nations General Assembly Seventy-fourth session Agenda items 14 and 120
Knowledge
Essential Medicines
Published by: United Nations
COVID-19 and non-communicable diseases: systematic mapping of registered clinical trials
Publication
The George Institute undertook a systematic analysis of global COVID-19 related registered clinical trials by mapping how they relate to noncommunicable diseases (NCDs). Our analysis outlines the current challenges, and provides recommendations about what we can do even better in the future.
Published by: The George Institute for Global Health
Pulse survey on continuity of essential health services during the COVID-19 pandemic: interim report
Report
The Pulse survey on continuity of essential health services during the COVID-19 pandemic aimed to gain initial insight from country key informants into the impact of the COVID-19 pandemic on essential health services across the life course. The survey results in this interim report can improve our understanding of the extent of disruptions across all services, the reasons for disruptions, and the mitigation strategies countries are using to maintain service delivery.
Published by: World Health Organization
Palliative Care
Fact sheet
Palliative care is an approach that improves the quality of life of patients (adults and children) and their families who are facing problems associated with life-threatening illness. It prevents and relieves suffering through the early identification, correct assessment and treatment of pain and other problems, whether physical, psychosocial or spiritual.
Published by: World Health Organization
The Power of Cities: Tackling Noncommunicable Diseases and Road Traffic Injuries
Report
Addressing the challenge of NCDs and road safety requires national and city authorities to work closely together. This report is a call for city leaders to rise to the challenge and show the world how local action can help solve global health problems.
Published by: World Health Organization
WHPA Health Improvement Card
Database
Improving global health through positive changes in behaviour and lifestyle, to reduce the 36 million death burden from non-communicable diseases.
Published by: International Federation of Pharmaceutical Manufacturers & Associations (IFPMA)
World Cancer Report: Cancer Research for Cancer Prevention
Report
The report focuses on prevention and offers the most comprehensive overview of relevant research avaliable to date, ranging from descriptive etiology, cellular and molecular biology, toxicology and pathology through to behavioural and social sciences. Key chapters include discussions on the impact of inequities in cancer, vaccination and screening, genomic individual susceptibility to cancer and the finer identification of those at risk, which may allow 'precision cancer prevention'.
Published by: International Agency for Research on Cancer
Global Hearts Initiative
Fact sheet
To support governments in strengthening the prevention and control of cardiovascular diseases (CVDs), in 2016 WHO and the United States Centers for Disease Control and Prevention (US CDC) launched the Global Hearts Initiative.
The Initiative comprises five technical packages which provide a set of high-impact, evidence-based interventions that, when used together, will have a major impact on improving global heart health.
Published by: World Health Organization (WHO)
Universal Health Coverage and Palliative Care: Do not leave those suffering behind
Report
This report, published on the first-ever Universal Health Coverage Day, highlights the current situation in relation to hospice and palliative care and UHC and makes recommendations for working towards the greater inclusion of palliative care within Universal Health Coverage policies and schemes.
Published by: Worldwide Hospice and Palliative Care Alliance
Follow-up to the high-level meetings of the United Nations General Assembly on NCDs
Report
The report is submitted in response to resolution WHA71.2 (2018), which “requests the Director-General to report to the Seventy-second World Health Assembly, through the Executive Board, on the outcomes of the third High-level Meeting of the General Assembly on the Prevention and Control of Non-communicable Diseases and its follow-up.
Published by: World Health Organization (WHO)
Follow-up to the high-level meetings of the United Nations General Assembly on NCDs
Report
The report is submitted in response to resolution WHA71.2 (2018), which “requests the Director-General to report to the Seventy-second World Health Assembly, through the Executive Board, on the outcomes of the third High-level Meeting of the General Assembly on the Prevention and Control of Non-communicable Diseases and its follow-up.
Published by: World Health Organization (WHO)
Follow-up to the high-level meetings of the United Nations General Assembly on NCDs
Report
The report is submitted in response to resolution WHA71.2 (2018), which “requests the Director-General to report to the Seventy-second World Health Assembly, through the Executive Board, on the outcomes of the third High-level Meeting of the General Assembly on the Prevention and Control of Non-communicable Diseases and its follow-up.
Published by: World Health Organization (WHO)
Follow-up to the high-level meetings of the United Nations General Assembly on NCDs
Report
The report is submitted in response to resolution WHA71.2 (2018), which “requests the Director-General to report to the Seventy-second World Health Assembly, through the Executive Board, on the outcomes of the third High-level Meeting of the General Assembly on the Prevention and Control of Non-communicable Diseases and its follow-up.
Published by: World Health Organization (WHO)
Follow-up to the high-level meetings of the United Nations General Assembly on NCDs
Report
The report is submitted in response to resolution WHA71.2 (2018), which “requests the Director-General to report to the Seventy-second World Health Assembly, through the Executive Board, on the outcomes of the third High-level Meeting of the General Assembly on the Prevention and Control of Non-communicable Diseases and its follow-up.
Published by: World Health Organization (WHO)
Exploring the Expansion of the Medicines Patent Pool’s Mandate to Patented Essential Medicines: A Feasibility Study of the Public Health Needs and Potential Impact
Case study
The Medicines Patent Pool (MPP) conducted a feasibility study to assess the public health need for – and the feasibility and potential public health impact of – expanding its mandate from HIV, tuberculosis and hepatitis C to patented essential medicines in other therapeutic areas. This includes medicines for different type of cancers (e.g. prostate, lung, multiple myeloma), sexual and reproductive health (e.g. heat-stable carbetocin), multiple sclerosis, cardiovascular diseases (e.g. the direct oral anticoagulants) and several new antibiotics.
MPP developed this feasibility study after the World Health Organization (WHO) and the Lancet Commission on Essential Medicines Policies, recommended the expansion of the MPP’s patent pooling model to all patented essential medicines, such as those included on the WHO Model List of Essential Medicines.
Published by: Medicines Patent Pool (MPP)
